Gainers

• Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday's after-market session. The company's market cap stands at $4.2 million.
• Caris Life Sciences (NASDAQ:CAI) stock moved upwards by 13.98% to $18.75. The company's market cap stands at $4.5 billion. As per the news, the Q2 earnings report came out today.
• Clover Health Investments (NASDAQ:CLOV) stock moved upwards by 11.35% to $4.61. The company's market cap stands at $2.2 billion. The company's, Q2 earnings came out today.
• Arcutis Biotherapeutics (NASDAQ:ARQT) stock moved upwards by 10.14% to $29.85. The company's market cap stands at $3.2 billion. As per the press release, Q2 earnings came out today.
• Myomo (AMEX:MYO) shares moved upwards by 9.27% to $1.16. The company's market cap stands at $41.7 million. As per the news, the Q2 earnings report came out today.
• Orthofix Medical (NASDAQ:OFIX) shares increased by 9.11% to $11.37. The market value of their outstanding shares is at $493.1 million. The company's, Q2 earnings came out today.

Losers

• BillionToOne (NASDAQ:BLLN) shares fell 24.7% to $113.0 during Wednesday's after-market session. The company's market cap stands at $6.5 billion. As per the press release, Q3 earnings came out today.
• Emergent BioSolutions (NYSE:EBS) stock fell 22.55% to $5.84. The company's market cap stands at $392.1 million. As per the press release, Q2 earnings came out today.
• Mirum Pharmaceuticals (NASDAQ:MIRM) stock declined by 20.6% to $84.0. The company's market cap stands at $6.3 billion. As per the news, the Q2 earnings report came out today.
• Akebia Therapeutics (NASDAQ:AKBA) shares decreased by 20.16% to $1.03. The company's market cap stands at $354.1 million. As per the news, the Q2 earnings report came out today.
• Biote (NASDAQ:BTMD) stock decreased by 14.61% to $1.93. The market value of their outstanding shares is at $68.8 million. As per the news, the Q2 earnings report came out today.
• Zhengye Biotechnology (NASDAQ:ZYBT) stock fell 12.72% to $2.06. The market value of their outstanding shares is at $60.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.